Lifezone Metals Limited (LZM)
USD 6.71
(-4.42%)
USD 6.71
(-4.42%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -26.41 Million | -17.03 Million | 1.38 Million | -260.64 Thousand |
| Net Income | -363.87 Million | -25.37 Million | -9.14 Million | 8906.00 |
| Depreciation & Amortization | 1.04 Million | 318.12 Thousand | 62.64 Thousand | 51.86 Thousand |
| Deferred income taxes | -276.23 Million | - | -7592.00 | - |
| Stock-based compensation | 265.55 Million | - | 9.98 Million | - |
| Change in working capital | -9.66 Million | 7.89 Million | 963.85 Thousand | -318.46 Thousand |
| Other non-cash items | 356.74 Million | 133.95 Thousand | -10.38 Thousand | -2949.00 |
| Investing Cash Flow | -60.5 Million | -7.96 Million | -106.96 Thousand | 230.32 Thousand |
| Investments in PPE | -52.43 Million | -6.17 Million | -110.24 Thousand | -148.58 Thousand |
| Acquisitions | -8.07 Million | -2 Million | -7.99 Million | - |
| Investment purchases | - | - | -281.52 Million | - |
| Sales/Maturities of investments | - | - | 289.51 Million | - |
| Other Investing Activities | 177.96 Thousand | 214.25 Thousand | 3278.00 | 378.9 Thousand |
| Financing Cash Flow | 115.74 Million | -80.93 Thousand | 9.76 Million | - |
| Debt repayment | -338.17 Thousand | -80.93 Thousand | - | - |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | -4.69 Million | - | 10 Million | - |
| Other Financing Activities | 116.08 Million | - | -240 Thousand | - |
| Accounts receivables | -1.97 Million | -2.59 Million | 367.07 Thousand | -165.22 Thousand |
| Accounts payables | -6.56 Million | 12.24 Million | 1.66 Million | - |
| Inventory | -51.04 Thousand | -49.73 Thousand | -1.66 Million | - |
| Other working capital | -1.07 Million | -1.7 Million | 596.78 Thousand | -153.24 Thousand |
| Cash at beginning of period | 18.81 Thousand | 45.62 Million | 600.08 Thousand | 630.41 Thousand |
| Cash at end of period | 49.39 Million | 20.53 Million | 11.63 Million | 600.08 Thousand |
| Capital Expenditure | -52.43 Million | -6.17 Million | -110.24 Thousand | -148.58 Thousand |
| Effect of forex changes on cash | 40.37 Thousand | -8137.00 | - | - |
| Net cash flow / Change in cash | 49.37 Million | -25.08 Million | 11.03 Million | -30.32 Thousand |
| Free Cash Flow | -78.85 Million | -23.2 Million | 1.27 Million | -409.23 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.75 Million | -3.84 Million | -4.72 Million | -363.87 Million | -347.7 Million | -5.66 Million |
| Depreciation & Amortization | 439.52 Thousand | 486.23 Thousand | 69.73 Thousand | 1.04 Million | 764.2 Thousand | 104.67 Thousand |
| Deferred income taxes | - | - | - | -276.23 Million | -265.55 Million | - |
| Stock-based compensation | - | - | - | 265.55 Million | 265.55 Million | - |
| Change in working capital | 1.02 Million | - | -3.13 Million | -9.66 Million | -13.25 Million | 5.97 Million |
| Other non-cash items | 1.1 Million | -306.27 Thousand | 4.64 Million | 356.74 Million | 342.61 Million | -101.59 Thousand |
| Investing Cash Flow | -15.46 Million | -11.28 Million | -21.51 Million | -60.5 Million | -21.13 Million | -14.59 Million |
| Investments in PPE | -28.03 Million | - | -21.52 Million | -52.43 Million | -13.14 Million | -14.73 Million |
| Acquisitions | - | - | 12.25 Thousand | -8.07 Million | -8.08 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 12.57 Million | -11.28 Million | 397.00 | 177.96 Thousand | 87.28 Thousand | 136.7 Thousand |
| Financing Cash Flow | 3.58 Million | 45.64 Million | 719.07 Thousand | 115.74 Million | 67.58 Million | -31.38 Thousand |
| Debt repayment | - | - | -158.94 Thousand | -338.17 Thousand | -116.44 Thousand | -31.38 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 877.99 Thousand | -4.69 Million | 70.17 Million | - |
| Other Financing Activities | 3.58 Million | 45.64 Million | 878.02 Thousand | 116.08 Million | 67.7 Million | - |
| Accounts receivables | -810.62 Thousand | - | -1.07 Million | -1.97 Million | 235.92 Thousand | -1.14 Million |
| Accounts payables | - | - | -1.86 Million | -6.56 Million | - | - |
| Inventory | -180.65 Thousand | - | 3876.00 | -51.04 Thousand | -37.71 Thousand | -26.78 Thousand |
| Other working capital | 2.01 Million | - | -206.52 Thousand | -1.07 Million | -13.45 Million | 7.15 Million |
| Cash at beginning of period | 79.59 Million | 49.39 Million | 73.25 Million | 18.81 Thousand | 44.41 Million | 58.72 Million |
| Cash at end of period | 63.49 Million | 79.59 Million | 49.39 Million | 49.39 Million | 73.25 Million | 44.41 Million |
| Capital Expenditure | -28.03 Million | - | -21.52 Million | -52.43 Million | -13.14 Million | -14.73 Million |
| Effect of forex changes on cash | -42.01 Thousand | - | 65.74 Thousand | 40.37 Thousand | -24.97 Thousand | - |
| Net cash flow / Change in cash | -16.1 Million | 30.2 Million | -23.86 Million | 49.37 Million | 28.84 Million | -14.31 Million |
| Free Cash Flow | -32.22 Million | -4.15 Million | -24.66 Million | -78.85 Million | -30.71 Million | -14.42 Million |
CAG
NG
ADV
BIOG-B
LGI
GISS